Measuring Risk Factors for Non-Adherence Using Patient-Reported Outcomes in Studies Evaluating Adherence with Oral Antineoplastic Agents: A 10-year Review

 

Measuring Risk Factors for Non-Adherence Using Patient-Reported Outcomes in Studies Evaluating Adherence with Oral Antineoplastic Agents: A 10-year Review

With oral antineoplastic agents (OAAs) becoming the mainstay of treatment for several cancer types, understanding risk factors for medication non-adherence is becoming increasingly important in oncology. Patient-reported outcome (PRO) instruments may provide valuable insight on barriers to medication adherence in the real world. This study sought to identify and describe key patient-reported risk factors for non-adherence measured in observational studies evaluating adherence with OAAs.